Figure 1
![Figure 1. Odds ratios for the prevalence of risk factors in patients with pregnancy complications. ORs were 0.9 (95% CI [bar]: 0.5-1.7) for age 35 years or younger, 0.8 (95% CI: 0.4-1.7) for parity, 1 (95% CI: 0.5-2.0) for the presence of abortion risk factor, 1.2 (95% CI: 0.7-2.3) for the presence of thrombophilia, 1 (95% CI: 0.5-2.2) for thrombocytosis exceeding 1000 × 109/L, 0.7 (95% CI: 0.4-1.3) for leukocytosis exceeding 10 × 109/L, 2 (95% CI: 1.1-3.8) for the presence of JAK2 (617V>F) mutation, and 0.9 (95% CI: 0.5-1.6) for antiplatelet therapy during pregnancy. The JAK2 (617V>F) mutation was a significant risk factor for pregnancy complications.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/110/2/10.1182_blood-2007-01-071068/4/zh80140704990001.jpeg?Expires=1735562606&Signature=XSocAeeHaNOaE54ZAyBeMbgZ8SV~gXEEOqTRiwgT~1KEr3v0spsBcoytD2DFqswAMnzk9wtxAgy1QEE7SKHA2I7X6WgEqURj0aHmaeLwYdUXEorsf~nzrjcTm79isjVIyZuSuJnFcwHR-ZDUHMeBvjz1~BET0~29ekRWwz3q6MeUhrO-1C7AyCqOHz2il2t-YRPgRw-K42Ixuc-Y3h7v4TwYqD9s~~dV5CnK6Mx6kgeeOS6FL5t~cPb6-k1xta-pTG~JHkKnpZwgRv0R~0dae-rbOWuy7RpIp1ZOonLAcg6KntVhp9Tn0lM0ocez24By~2kdUMo5~E53dW~BO4fMkw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Odds ratios for the prevalence of risk factors in patients with pregnancy complications. ORs were 0.9 (95% CI [bar]: 0.5-1.7) for age 35 years or younger, 0.8 (95% CI: 0.4-1.7) for parity, 1 (95% CI: 0.5-2.0) for the presence of abortion risk factor, 1.2 (95% CI: 0.7-2.3) for the presence of thrombophilia, 1 (95% CI: 0.5-2.2) for thrombocytosis exceeding 1000 × 109/L, 0.7 (95% CI: 0.4-1.3) for leukocytosis exceeding 10 × 109/L, 2 (95% CI: 1.1-3.8) for the presence of JAK2 (617V>F) mutation, and 0.9 (95% CI: 0.5-1.6) for antiplatelet therapy during pregnancy. The JAK2 (617V>F) mutation was a significant risk factor for pregnancy complications.
